Massimilano Colao's most recent trade in Aurinia Pharmaceuticals Inc was a trade of 178,063 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 2, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc | Massimilano Colao | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 178,063 | 178,063 | - | - | Stock Option (right to buy) | |
| Aurinia Pharmaceuticals Inc | Massimilano Colao | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 104,080 | 104,080 | - | - | Restricted Stock Unit | |
| Aurinia Pharmaceuticals Inc | Massimilano Colao | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 8,500 | 16,700 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharmaceuticals Inc | Massimilano Colao | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 02 Mar 2022 | 3,205 | 13,495 (0%) | 0% | 12.0 | 38,492 | Common Stock |